Clay Semenkovich, M.D.

Clay F. Semenkovich, M.D., is Chief of the Division of Endocrinology, Metabolism and Lipid Research, the Program Director of the Endocrinology, Diabetes and Metabolism fellowship program, a Professor of Medicine and of Cell Biology and Physiology, and Director of the CNRU’s Animal Model Research Core Laboratory. He has served as Assistant Program Director of the University's General Clinical Research Center and is the founding Program Director of the Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Program at the University. He has been Associate Editor of Diabetes, Associate Editor of the American Journal of Physiology, is currently a member of the Editorial Board for Arteriosclerosis, Thrombosis and Vascular Biology, and a permanent member of the Metabolism Study Section for the NIH. He has held a number of leadership positions in the American Diabetes Association, most recently Chair of the Research Policy Committee, and is currently a Councilor representing endocrinology for the Association of Subspecialty Professors.

He has received several Distinguished Service Teaching Awards from the Washington University School of Medicine. The Washington University Medical Center Alumni Association recently honored Dr. Semenkovich by the establishment of a Distinguished Alumni Scholarship.

Dr. Semenkovich's research is focused on connections between diabetes, insulin resistance and heart disease. He has used genetically manipulated mice to develop strategies for reversing insulin resistance, hypertension and diabetes, and to identify new mechanisms underlying both diabetes and atherosclerosis. He has also translated these observations to humans to enhance our understanding of how to alter risk factors for vascular disease.